Clinical Trial Update: Survey on the Treatment of Anemia Using Recombinant Human Erythropoietin 2 (STAR-2)

View source ↗

Summary

This clinical trial update reports on the STAR-2 survey evaluating the treatment of anemia in patients with neoplasms using recombinant human erythropoietin.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Neoplasms

Drugs mentioned

• Recombinant human erythropoietin 2 (STAR-2) (epoetin alfa)

Snippet

Sponsor: Janssen-Cilag B.V. | Conditions: Anemia, Neoplasms | Status: COMPLETED